BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30070213)

  • 21. Utilizing nullomers in cell-free RNA for early cancer detection.
    Montgomery A; Tsiatsianis GC; Mouratidis I; Chan CSY; Athanasiou M; Papanastasiou AD; Kantere V; Syrigos N; Vathiotis I; Syrigos K; Yee NS; Georgakopoulos-Soares I
    Cancer Gene Ther; 2024 Jun; 31(6):861-870. PubMed ID: 38351138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in circulating nucleic acids in oncology.
    Otandault A; Anker P; Al Amir Dache Z; Guillaumon V; Meddeb R; Pastor B; Pisareva E; Sanchez C; Tanos R; Tousch G; Schwarzenbach H; Thierry AR
    Ann Oncol; 2019 Mar; 30(3):374-384. PubMed ID: 30753271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cells and cell-free nucleic acids in patients with gynecological malignancies.
    Davidson B
    Virchows Arch; 2018 Oct; 473(4):395-403. PubMed ID: 30145616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid biopsy: a holy grail for cancer detection.
    Sorbara L; Srivastava S
    Biomark Med; 2019 Aug; 13(12):991-994. PubMed ID: 31464153
    [No Abstract]   [Full Text] [Related]  

  • 26. Early detection and monitoring of cancer in liquid biopsy: advances and challenges.
    Xue VW; Wong CSC; Cho WCS
    Expert Rev Mol Diagn; 2019 Apr; 19(4):273-276. PubMed ID: 30760042
    [No Abstract]   [Full Text] [Related]  

  • 27. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
    Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
    Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid Biopsy - The Non-invasive Tool for Tracking Cancer.
    Baig S; Jafarey O
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):417-418. PubMed ID: 29848413
    [No Abstract]   [Full Text] [Related]  

  • 29. Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions.
    Sorber L; Zwaenepoel K; Jacobs J; De Winne K; Van Casteren K; Augustus E; Lardon F; Prenen H; Peeters M; Van Meerbeeck J; Roeyen G; Rolfo C; Pauwels P
    Mol Diagn Ther; 2020 Feb; 24(1):113-124. PubMed ID: 31838654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential of circulating cell free RNA as a biomarker in cancer.
    Cheung KWE; Choi SR; Lee LTC; Lee NLE; Tsang HF; Cheng YT; Cho WCS; Wong EYL; Wong SCC
    Expert Rev Mol Diagn; 2019 Jul; 19(7):579-590. PubMed ID: 31215265
    [No Abstract]   [Full Text] [Related]  

  • 31. A biocomposite-based rapid sampling assay for circulating cell-free DNA in liquid biopsy samples from human cancers.
    Koo B; Jun E; Liu H; Kim EJ; Park YY; Lim SB; Kim SC; Shin Y
    Sci Rep; 2020 Sep; 10(1):14932. PubMed ID: 32913285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood Test Flags Multiple Cancers in Large Study.
    Abbasi J
    JAMA; 2020 Jun; 323(22):2239. PubMed ID: 32515803
    [No Abstract]   [Full Text] [Related]  

  • 33. The contribution of the 20th century discoveries on the circulating DNA as biomarkers for cancer screening.
    Alves G; Chantre M; Delmonico L
    An Acad Bras Cienc; 2020; 92(4):e20200919. PubMed ID: 33206793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of cell-free DNA liquid biopsies in Merkel cell carcinoma.
    Shalhout SZ; Emerick K; Kaufman HL; Miller DM
    Dermatol Online J; 2021 Oct; 27(10):. PubMed ID: 35130390
    [No Abstract]   [Full Text] [Related]  

  • 35. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection.
    Pantel K
    PLoS Med; 2016 Dec; 13(12):e1002205. PubMed ID: 28027295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early detection of primary liver cancer using plasma cell-free DNA fragmentomics: Do all the pieces come together?
    Agopian VG; Yang JD; Zhu Y; You S; Tseng HR
    Hepatology; 2022 Aug; 76(2):289-291. PubMed ID: 35124841
    [No Abstract]   [Full Text] [Related]  

  • 38. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of liquid biopsy in glioblastoma - A review.
    Klekner Á; Szivos L; Virga J; Árkosy P; Bognár L; Birkó Z; Nagy B
    J Biotechnol; 2019 Jun; 298():82-87. PubMed ID: 30986516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid biopsy: a perspective for probing blood for cancer.
    Jeffrey SS; Toner M
    Lab Chip; 2019 Feb; 19(4):548-549. PubMed ID: 30688954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.